Review by two specialists remains in place for patients initiating valproate under 55 years of age but the Commission on Human Medicines (CHM) has advised that it will not be required for men (or males) currently taking valp…
UK Drug Safety Update · February 13, 2025
Valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epilim Chrono or Chronosphere, Episenta, Epival, and Syonell): review by two specialists required for initiating but not for male patients already taking valproate
Original title: Valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epilim Chrono or Chronosphere, Episenta, Epival, and Syonell▼): review by two specialists is required for initiating valproate but not for male patients already taking valproate
Two-specialist review requirement for valproate initiation under 55 years removed for men already taking the medicine.
Published by UK Drug Safety Update. HealthSignal links to the original document; the summary above is extracted from the source text.